Medication info

CandroPlus Tablet

Prescription medicationApproval withdrawn
Ingredient · strength
Candesartan Cilexetil›Strength being verifiedHydrochlorothiazide›Strength being verified
Manufacturer / importer
Dongwhah Pharmaceutical Co., Ltd.
Appearance
Biconvex light pink rectangular tablets
Packaging
30 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 200904370 · Notified 2009.06.23

This product's status changed to Approval withdrawn on 2023.09.06. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension not controlled with a single component
Who uses it
Adults
Adult dosage
The recommended dose of this medicine is 1 tablet once daily, taken with or without food. 1) Adults: The dose of candesartan cilexetil should first be adjusted before switching to this medicine. When clinically appropriate, a direct switch from monotherapy to this medicine may be considered. The antihypertensive effect is generally achieved within 4 weeks of starting treatment. 2) Elderly patients: No dosage adjustment of this medicine is necessary for elderly patients. 3) Patients with intravascular volume depletion: Dose adjustment of candesartan cilexetil is recommended in patients at risk of hypotension, such as those who may have reduced effective circulating blood volume (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and a creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the dose of candesartan cilexetil before switching to this medicine (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance less than 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: It is recommended that the dose of candesartan cilexetil be adjusted before administering this medicine to patients with mild to moderate hepatic impairment (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Ingredients

Manufacturer
Dongwhah Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with a single component

  • Essential hypertension
View approved original text

Essential hypertension may not be sufficiently controlled by individual component therapies alone, and in such cases, combination therapy is required to control blood pressure. This medication is particularly used to assist in controlling blood pressure in patients with essential hypertension, stabilizing blood pressure and reducing the risk of cardiovascular complications.

Dosage and Administration

Adult dosage

The recommended dose of this medicine is 1 tablet once daily, taken with or without food. 1) Adults: The dose of candesartan cilexetil should first be adjusted before switching to this medicine. When clinically appropriate, a direct switch from monotherapy to this medicine may be considered. The antihypertensive effect is generally achieved within 4 weeks of starting treatment. 2) Elderly patients: No dosage adjustment of this medicine is necessary for elderly patients. 3) Patients with intravascular volume depletion: Dose adjustment of candesartan cilexetil is recommended in patients at risk of hypotension, such as those who may have reduced effective circulating blood volume (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and a creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the dose of candesartan cilexetil before switching to this medicine (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance less than 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: It is recommended that the dose of candesartan cilexetil be adjusted before administering this medicine to patients with mild to moderate hepatic impairment (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. Individuals who have allergies to the ingredients or sulfonamide derivatives contained in this medication, pregnant women or those planning to become pregnant, breastfeeding women, patients with severe kidney or liver disorders, and those with a history of certain hereditary diseases or angioedema should not take this medication. Patients with reduced blood volume or low sodium levels, liver disease, cardiac valve disease, hyperkalemia, severe arteriosclerosis, elderly individuals, etc., should use this medication with special caution. This medication may cause various side effects such as headache, dizziness, fatigue, dyspepsia, skin rash, and can sometimes lead to changes in blood test values or, rarely, serious allergic reactions. There is an increased risk of skin cancer, so sun exposure should be minimized, and skin conditions should be checked regularly. If any suspicious lesions are found, a doctor should be consulted immediately. During treatment, blood pressure, kidney function, and electrolyte levels should be regularly monitored. When combined with other antihypertensive medications or diuretics or certain drugs, the risk of side effects may increase due to interactions, so it is essential to consult with medical professionals. Pregnant or breastfeeding women should not take this medication, and if necessary during breastfeeding, they must discontinue breastfeeding. Safety in children and adolescents under 18 years of age has not been established, so caution is advised in usage. In elderly patients, there is a risk of myocardial infarction, stroke, or deterioration of renal function due to excessive blood pressure lowering, so careful administration is necessary. In the case of overdose, symptoms such as hypotension, dizziness, and electrolyte imbalance may appear, so in case of suspicion, contact a medical institution immediately for appropriate treatment. This medication should be stored out of reach of children and kept in its original container to prevent misuse or degradation of quality.

Side effects

  • Headache
  • back pain
  • dizziness
  • respiratory infections
  • symptoms similar to influenza
  • sinusitis
  • bronchiolitis
  • urinary tract infection
  • nausea
  • contusions
Show 71 more
  • tachycardia
  • fatigue
  • abdominal pain
  • pharyngitis
  • atrioventricular block
  • vomiting
  • dyslipidemia
  • rhinopharyngitis
  • cough
  • elevated blood sugar
  • increased serum uric acid
  • elevated ALT
  • decreased hemoglobin
  • increased serum AST
  • increased creatinine
  • elevated urea
  • increased potassium
  • decreased sodium
  • leukopenia
  • neutropenia
  • agranulocytosis
  • vertigo
  • diarrhea
  • renal failure
  • angioedema
  • rash
  • urticaria
  • pruritus
  • arthralgia
  • myalgia
  • hyperkalemia
  • hyponatremia
  • increased liver enzyme levels
  • abnormal liver function
  • hepatitis
  • cardiac arrhythmia
  • sensory disturbances
  • blurred vision
  • choroidal effusion
  • acute myopia
  • acute angle-closure glaucoma
  • dyspnea
  • acute respiratory distress syndrome
  • anorexia
  • loss of appetite
  • gastrointestinal irritation
  • constipation
  • pancreatitis
  • interstitial nephritis
  • rash
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus erythematosus-like skin response
  • activation of lupus erythematosus
  • muscle cramps
  • hyperglycemia
  • hyperuricemia
  • electrolyte imbalance
  • orthostatic hypotension
  • necrotizing vasculitis
  • weakness
  • fever
  • anaphylactic reaction
  • jaundice
  • sleep disorders
  • depression
  • anxiety
  • edema
  • myalgia
  • hypercalcemia
  • otalgia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air or moisture, so it should be stored in a tightly closed container. Additionally, it should be kept in a cool place below 30 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

Biconvex light pink rectangular tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.